Literature DB >> 6235072

Interleukin-2 activity in chronic active liver diseases: response by T cells and in the autologous mixed lymphocyte reaction.

K Yoshioka, S Kakumu, H Murakami, K Fukui.   

Abstract

The T cell growth factor, interleukin-2 (IL-2), is a lymphokine which supports the immunoregulatory function of T cells. We measured the production of and response to IL-2 of peripheral blood T cell subsets from patients with chronic active liver diseases (CALD) and other liver diseases (Others) by the proliferative response of the cells activated with phytohaemogglutin P. Both production of and response to IL-2 of T cells from 24 patients with CALD were markedly decreased (P less than 0.001) in comparison with 13 controls. T cells from 10 patients with Others yielded low IL-2 titre (P less than 0.05) and responded to IL-2 in a depressed manner (P less than 0.05). OKT4+ and OKT8+ cells from five CALD patients as well as five controls equally produced IL-2 and responded to it. However, IL-2 production (P less than 0.05) and response to IL-2 (P less than 0.01) of OKT4+ cells from CALD patients were decreased in contrast to those of OKT8+ cells. We also examined the effect of IL-2 on the autologous mixed lymphocyte reaction. A highly significant increase (P less than 0.001) in the proliferative response of OKT8+ cells and unseparated T cells from 15 patients with CALD occurred with the addition of IL-2 although the values were still lower (P less than 0.01) than those of OKT8+ and unseparated T cells from 12 controls. Addition of IL-2 did not result in a significant increase of the reactivity of OKT4+ cells from patients with CALD. These results further delineate the nature of the immunoregulatory aberration in CALD.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6235072      PMCID: PMC1535987     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  21 in total

1.  A monoclonal antibody reactive with the human cytotoxic/suppressor T cell subset previously defined by a heteroantiserum termed TH2.

Authors:  E L Reinherz; P C Kung; G Goldstein; S F Schlossman
Journal:  J Immunol       Date:  1980-03       Impact factor: 5.422

2.  Lymphocyte cytotoxicity against Chang liver cells in chronic active hepatitis.

Authors:  S Kakumu; T Hara; H Goji; N Sakamoto
Journal:  Cell Immunol       Date:  1978-03-01       Impact factor: 4.868

Review 3.  Interleukin 2: a class of T cell growth factors.

Authors:  J Watson; D Mochizuki
Journal:  Immunol Rev       Date:  1980       Impact factor: 12.988

Review 4.  Cellular origins and targets of costimulator (IL2).

Authors:  V Paetkau; J Shaw; G Mills; B Caplan
Journal:  Immunol Rev       Date:  1980       Impact factor: 12.988

Review 5.  The differentiation and function of human T lymphocytes.

Authors:  E L Reinherz; S F Schlossman
Journal:  Cell       Date:  1980-04       Impact factor: 41.582

6.  Further characterization of the human inducer T cell subset defined by monoclonal antibody.

Authors:  E L Reinherz; P C Kung; G Goldstein; S F Schlossman
Journal:  J Immunol       Date:  1979-12       Impact factor: 5.422

7.  Antibody-dependent cell-mediated cytotoxicity (ADCC) and cell-mediated cytotoxicity (CMC) to HBsAg-coated target cells in patients with hepatitis B and chronic hepatitis (CAH).

Authors:  H Warnatz; W Rösch; W Gerlich; W Gutmann
Journal:  Clin Exp Immunol       Date:  1979-01       Impact factor: 4.330

8.  Decreased autologous mixed lymphocyte reaction in Sjögren's syndrome.

Authors:  N Miyasaka; B Sauvezie; D A Pierce; T E Daniels; N Talal
Journal:  J Clin Invest       Date:  1980-11       Impact factor: 14.808

9.  Immunoregulatory T-cell function in acute and chronic liver disease.

Authors:  S Kakumu; K Yata; T Kashio
Journal:  Gastroenterology       Date:  1980-10       Impact factor: 22.682

10.  Autologous stimulation of human lymphocyte subpopulation.

Authors:  G Opelz; M Kiuchi; M Takasugi; P I Terasaki
Journal:  J Exp Med       Date:  1975-11-01       Impact factor: 14.307

View more
  10 in total

1.  Interleukin-1 and -2 in sera of patients with chronic hepatitis (type B).

Authors:  T Ozeki; K Imanishi; H Unoki; K Funakoshi; Y Kiya
Journal:  Int J Exp Pathol       Date:  1990-12       Impact factor: 1.925

2.  Functional analysis of peripheral blood lymphocytes isolated from patients with chronic hepatitis type B.

Authors:  C García-Monzón; R Moreno-Otero; L García-Buey; M López-Botet; M O De Landázuri; F Sánchez-Madrid
Journal:  Dig Dis Sci       Date:  1992-01       Impact factor: 3.199

3.  Patients with spontaneous bacterial peritonitis, and malignant and cirrhotic ascites.

Authors:  Bulent Yildirim; Ramazan Sari; Nuran Isci
Journal:  J Natl Med Assoc       Date:  2005-02       Impact factor: 1.798

4.  Studies of proliferative responses by long-term-cryopreserved peripheral blood mononuclear cells to bacterial components associated with periodontitis.

Authors:  G A Miller; M F Hickey; M M D'Alesandro; B K Nicoll
Journal:  Clin Diagn Lab Immunol       Date:  1996-11

5.  Proliferation and immunoglobulin synthesis of peripheral blood mononuclear cells from patients with chronic liver disease stimulated by Staphylococcus aureus Cowan 1 and interleukin 2.

Authors:  S Kakumu; A Fuji; Y Ohtani; K Murase; H Hirofuji; H Tahara
Journal:  Gastroenterol Jpn       Date:  1987-06

6.  Decreased proliferative activity associated with activation markers in patients with alcoholic liver cirrhosis.

Authors:  J Devière; C Denys; L Schandene; F Romasco; M Adler; J Wybran; E Dupont
Journal:  Clin Exp Immunol       Date:  1988-06       Impact factor: 4.330

7.  Interleukin 2 receptor bearing T lymphocytes in patients with chronic liver disease.

Authors:  S Kakumu; K Yoshioka; A Fuji; H Tahara
Journal:  Gastroenterol Jpn       Date:  1988-08

8.  Expression rate of cytokine mRNA in the liver of chronic hepatitis C: comparison with chronic hepatitis B.

Authors:  R Fukuda; S Satoh; X T Nguyen; Y Uchida; N Kohge; S Akagi; S Ikeda; M Watanabe; S Fukumoto
Journal:  J Gastroenterol       Date:  1995-02       Impact factor: 7.527

9.  Interleukin 2 activity in chronic liver disease and the effect of in vitro alpha-interferon.

Authors:  S Saxena; K T Nouri-Aria; M G Anderson; A L Eddleston; R Williams
Journal:  Clin Exp Immunol       Date:  1986-03       Impact factor: 4.330

10.  Impaired autologous mixed-lymphocyte reaction of peripheral blood lymphocytes in adult periodontitis.

Authors:  S Kimura; N Fujimoto; H Okada
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.